DC11704 |
CFI-401870 |
A potent, selective, orally active Mps1 (TTK) inhibitor with IC50 of 3.1 nM. |
|
DC11677 |
CCT-271850 |
A potent, selective, orally bioavailable Mps1 kinase inhibitor with IC50 of 11 nM. |
|
DC7072 |
AZ3146
Featured
|
AZ3146 is a potent and selective monopolar spindle 1 (Mps1) kinase inhibitor (IC50 = 35 nM); less potent to FAK, JNK1, JNK2, and Kit. |
|
DC9679 |
BAY1217389
Featured
|
BAY1217389 is an orally bioavailable, selective inhibitor of the serine/threonine kinase monopolar spindle 1 (Mps1, TTK), with potential antineoplastic activity. |
|
DC7470 |
MPI-0479605
Featured
|
MPI-0479605 is an ATP competitive and selective inhibitor of mitotic kinase Mps1 with IC50 of 1.8 nM, >40-fold selectivity over other kinases. |
|
DC8119 |
Mps1-IN-2
Featured
|
Mps1-IN-2 is a potent Mps1 kianse inhibitor with IC50 value of 145 nM. |
|
DC5087 |
Mps1-IN-1 |
Mps1-IN-1 is a highly potent and selectibe Mpsl inhibitor with IC50 of 367 nM; >1000-fold selectivity relative to the 352 member kinase panel with the major exceptions of Alk and Ltk. |
|
DC7866 |
NMS-P715
Featured
|
NMS-P715 is the first selective, ATP-competitive and orally bioavailable MPS1 small-molecule inhibitor(IC50=8 nM); selectively reduces cancer cell proliferation, leaving normal cells almost unaffected. |
|
DC28264 |
TC-Mps1-12 |
TC-Mps1-12 is a potent and selective monopolar spindle 1 (Mps1) inhibitor, with an IC50 of 6.4 nM. |
|
DC70063 |
CFI-402257(luvixasertib)
Featured
|
CFI-402257(luvixasertib) is a potent and selective Mps1/TTK kinase inhibitor with Ki of 0.1 nM and cellular Mps1 EC50 of 6.5 nM. |
|
DC73202 |
SYL1073 |
SYL1073 is a potent, selective and covalent Threonine tyrosine kinase (TTK) inhibitor with IC50 of of 16 nM. |
|